Global Sales Of Diabetic Foot Ulcer Treatment Market Are Valued At Around US$ 7.4 Billion In 2032, Opines AMR
According to the report, the global diabetic foot ulcer treatment market was valued at $4.4 billion in 2022 and is estimated to reach $7.4 billion by 2032, exhibiting a CAGR of 5.4% from 2023 to 2032. The report offers an in-depth analysis of the market size, emerging and current trends, future estimations, and key players.
The global diabetic foot ulcer treatment market is experiencing growth due to several factors, including an increase in the prevalence of diabetic foot ulcer cases, technological advancements in wound care management, and a rise in new product launches for diabetic foot ulcer treatment. However, stringent regulations for the manufacturing of wound care dressings and devices are hampering the growth of the diabetic foot ulcer treatment market. On the other hand, the growth opportunities in emerging countries are expected to offer remunerative opportunities for the expansion of the diabetic foot ulcer treatment market in the upcoming years.
Request Sample Report:
https://www.alliedmarketresearch.com/request-sample/111438
Market Dynamics
The major factors driving the growth of the diabetic foot ulcer treatment market are increase in prevalence of diabetes, rise in geriatric population, and rise in technological advancements in wound care management products. The rising global prevalence of diabetes is a significant driver for the market. For instance, as per National Diabetes Statistics Report by Centers for Disease Control and Prevention (CDC) in 2022, 130 million adults are living with diabetes or prediabetes in the U.S. As the prevalence of diabetes continues to rise, there is a corresponding increase in the demand for effective diabetic foot ulcer treatment options.
Impact of COVID-19 on Diabetic Foot Ulcer Treatment Market:
Negative Impacts:
- Reduced Access to Care: Lockdowns, fear of exposure to the virus, and prioritization of COVID-19 patients led to a decline in routine podiatric and diabetic foot care appointments. This delayed diagnoses and interventions for DFU patients, potentially worsening their condition.
- Disruptions in the Supply Chain: Global supply chain disruptions affected the availability of certain DFU treatment materials and equipment, such as specialized dressings, offloading devices, and negative pressure pumps. This delayed treatments and increased costs for some patients.
- Mental Health Burden: The pandemic-induced stress and anxiety negatively impacted the mental health of DFU patients, potentially affecting their adherence to treatment protocols and overall wound healing.
Positive Impacts:
- Increased Telemedicine Adoption: The pandemic accelerated the adoption of telemedicine in healthcare, enabling remote consultations and wound assessments for DFU patients. This improved access to care for those unable to visit clinics in person.
- Focus on Preventative Measures: The pandemic heightened awareness of the importance of preventative care for diabetic patients, including foot hygiene, blood sugar control, and early detection of foot complications. This could potentially lead to a decrease in DFU incidence in the long term.
- Research Focus on Wound Care Innovations: The need for effective and accessible DFU treatments during the pandemic spurred research and development efforts in advanced wound care technologies, such as bioengineered skin substitutes and telemonitoring systems. These advancements hold promise for improving DFU outcomes in the future.
Negative pressure wound therapy (NPWT) devices have gained popularity for diabetic foot ulcer treatment owing to their effectiveness in promoting wound healing. These devices create a vacuum environment that helps remove excess fluid, debris, and bacteria from the wound while promoting blood flow and tissue growth. Examples of FDA-approved NPWT devices for diabetic foot ulcer are V.A.C. Therapy of 3M Company and PICO from Smith & Nephew.
Request Customization:
https://www.alliedmarketresearch.com/request-for-customization/111438
Key Market Segments:
By Product
- Wound care dressings
- Wound care devices
- Biologics
By Type
- Neuropathic ulcers
- Ischemic ulcers
- Neuroischemic ulcers
By End user
- Hospitals
- Homecare settings
- Others
By Region
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, Spain, Rest of Europe)
- Asia-Pacific (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
- LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Findings of the Study
- On the basis of product, the wound care dressings segment dominated the market in terms of revenue in 2022. However, the wound care devices segment is expected to grow at the highest CAGR during the forecast period.
- Based on type, the neuroischemic ulcers segment accounted for largest share in terms of revenue in 2022 and is anticipated to witness highest CAGR during the diabetic foot ulcer treatment market forecast period.
- On the basis of end user, the homecare settings segment dominated the diabetic foot ulcer treatment industry in terms of revenue in 2022, and is anticipated to grow at the highest CAGR during the forecast period.
- Region wise, North America generated the largest revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Leading Market Players: –
- Convatec Group Plc
- 3m Company
- Cardinal Health Inc.
- Organogenesis Holdings Inc.
- Smith and Nephew Plc.
- B. Braun Se
- Coloplast
- Integra Lifesciences Holdings Corporation
- Molnlycke Health Care AB
- Essity Aktiebolag AB
Regional Growth:
North America held the major market share in 2022, accounting for nearly two-fifths of the global diabetic foot ulcer treatment market revenue, and is likely to maintain its dominance by 2032. owing to the rise in the prevalence of diabetic foot ulcers, the availability of well-developed healthcare infrastructure such as specialized wound care centers and diabetic clinics, and the growing emphasis on early detection and comprehensive management of diabetic foot ulcers. However, the Asia-Pacific region is expected to witness the fastest CAGR of 6.4% from 2023 to 2032, Owing to the rising prevalence of diabetes, increasing healthcare expenditure, and increasing awareness about the importance of early detection and treatment of diabetic foot ulcers, which are also expected to boost market growth.
For Purchase Inquiry-
https://www.alliedmarketresearch.com/purchase-enquiry/111438
Recent Acquisition in Diabetic Foot Ulcer Treatment Market
In December 2022, Essity acquired U.S.-based advanced wound care company, Hydrofera, developer of Blue Antibacterial Wound Dressings, an advanced line of wound care products designed to shorten healing times, lower treatment costs, and deliver better patient outcomes.
Other Trending Reports in Life Science Domain-
Oxygen Concentrators Market:
https://www.alliedmarketresearch.com/medical-oxygen-concentrators-market-A10874
Mobile Imaging Market:
https://www.alliedmarketresearch.com/mobile-imaging-services-market-A10893
Brachytherapy Market:
https://www.alliedmarketresearch.com/brachytherapy-market-A11122
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Contact Us:
David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
Editor Details
-
Company:
- The Wire Times
